TY  - GEN
AU  - Kaira,Kyoichi
AU  - Sunose,Yutaka
AU  - Ohshima,Yasuhiro
AU  - Ishioka,Noriko S
AU  - Arakawa,Kazuhisa
AU  - Ogawa,Tetsushi
AU  - Sunaga,Noriaki
AU  - Shimizu,Kimihiro
AU  - Tominaga,Hideyuki
AU  - Oriuchi,Noboru
AU  - Itoh,Hideaki
AU  - Nagamori,Shushi
AU  - Kanai,Yoshikatsu
AU  - Yamaguchi,Aiko
AU  - Segawa,Atsuki
AU  - Ide,Munenori
AU  - Mori,Masatomo
AU  - Oyama,Tetsunari
AU  - Takeyoshi,Izumi
TI  - Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer
SN  - 1471-2407
PY  - 2014///0321
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Antimetabolites, Antineoplastic
KW  - pharmacology
KW  - Biliary Tract Neoplasms
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Fusion Regulatory Protein-1
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Large Neutral Amino Acid-Transporter 1
KW  - Lymphatic Metastasis
KW  - Male
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Multivariate Analysis
KW  - Prognosis
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Xenograft Model Antitumor Assays
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2407-13-482
ER  -